0001140361-22-000875.txt : 20220106
0001140361-22-000875.hdr.sgml : 20220106
20220106210036
ACCESSION NUMBER: 0001140361-22-000875
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220105
FILED AS OF DATE: 20220106
DATE AS OF CHANGE: 20220106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Steenvoorden Lawrence J.
CENTRAL INDEX KEY: 0001902795
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35569
FILM NUMBER: 22516313
MAIL ADDRESS:
STREET 1: C/O CHEMBIO DIAGNOSTICS, INC.
STREET 2: 555 WIRELESS BOULEVARD
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHEMBIO DIAGNOSTICS, INC.
CENTRAL INDEX KEY: 0001092662
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880425691
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
BUSINESS PHONE: (631) 924-1135
MAIL ADDRESS:
STREET 1: 555 WIRELESS BLVD.
CITY: HAUPPAUGE
STATE: NY
ZIP: 11788
FORMER COMPANY:
FORMER CONFORMED NAME: Chembio Diagnostics Inc.
DATE OF NAME CHANGE: 20040607
FORMER COMPANY:
FORMER CONFORMED NAME: TRADING SOLUTIONS COM INC
DATE OF NAME CHANGE: 19990805
4
1
form4.xml
FORM 4
X0306
4
2022-01-05
0001092662
CHEMBIO DIAGNOSTICS, INC.
CEMI
0001902795
Steenvoorden Lawrence J.
C/O CHEMBIO DIAGNOSTICS, INC.
555 WIRELESS BOULEVARD
HAUPPAUGE
NY
11788
true
See remarks
Restricted stock units
2022-01-05
4
A
0
160714
0
A
Common stock
160714
160714
D
Nonqualified stock options
1.12
2022-01-05
4
A
0
300000
0
A
2029-01-05
Common stock
300000
300000
D
Each restricted stock unit represents a contingent right to receive one share of Common Stock
The restricted stock units are scheduled to vest in three equal installments on January 5, 2023, 2024 and 2025, provided they shall vest in full immediately prior to (a) the issuer's termination of the reporting person employment without Cause, the reporting person's termination of his employment for Good Reason or the expiration of the Term upon notice of nonrenewal delivered by the Company, in each case within twelve months following a Change in Control, or (b) the reporting person's death or Permanent Disability (each such capitalized term as defined in the employment agreement between the issuer and the reporting person).
The nonqualified stock options are scheduled to vest in four equal installments on January 5, 2023, 2024, 2025 and 2026, provided they shall vest in full immediately prior to (a) the issuer's termination of the reporting person's employment without Cause, the reporting person's termination of his employment for Good Reason or the expiration of the Term upon notice of nonrenewal delivered by the Company, in each case within twelve months following a Change in Control, or (b) the reporting person's death or Permanent Disability (each such capitalized term as defined in the employment agreement between the issuer and the reporting person).
Executive Vice President and Chief Financial Officer
/s/ Mark L. Johnson, Attorney-in-Fact for Lawrence J. Steenvoorden
2022-01-06